Globe Life's investment thesis is dominated by a severe underwriting shock in Q2 2026, where claims of $2.4B overwhelmed $1.6B in revenue, resulting in a 139.4% combined ratio and an operating loss of $629.6M. While historical revenue growth has decelerated fr...
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Q2 2026 marked a critical inflection with the loss ratio spiking to 150.3% and combined ratio to 139.4%, indicating core underwriting is severely unprofitable despite reported net income of $287.7M.
Globe Life has demonstrated consistent revenue and earnings growth, reporting $5.99 billion in revenue for 2025, a 3.74% increase from the previous year, and earnings rising by 8.45% to $1.16 billion. Recent earnings calls have highlighted double-digit net operating income growth and robust investment income.
The majority of Wall Street analysts have a positive outlook on GL stock, with a consensus rating of 'Buy' or 'Strong Buy.' Several analysts have raised their price targets, citing strong earnings and raised guidance.
The company anticipates continued premium growth in 2026, with life premiums projected to increase by 3%-3.5% and health premiums by 14%-17%. This growth is supported by a projected 10% increase in leads for its exclusive agencies.
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 22, 2026 | $3.61-1.6% vs $3.67 | $1.6B+0.6% vs $1.6B |
Q2 2026 Apr 22, 2026 | $3.43-1.2% vs $3.47 | $1.6B-0.3% vs $1.6B |
Q1 2026 Feb 4, 2026 | $3.39-1.5% vs $3.44 | $1.5B-0.8% vs $1.5B |
Q4 2025 Oct 22, 2025 | $4.81+4.6% vs $4.60 | $1.5B-0.4% vs $1.5B |
Globe Life expects premium growth, AI adoption and distribution expansion to support earnings, while strong capital enables substantial share buybacks.
Amundi raised its stake in Globe Life Inc. (NYSE: GL) by 307.4% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 162,223 shares of the company's stock after buying an additional 122,402 shares during the quarter. Amundi owned approximately 0.21% of Globe Life worth $28,986,000 as
Nykredit A S acquired a new position in Globe Life Inc. (NYSE: GL) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,562 shares of the company's stock, valued at approximately $636,000. A number of other institutional investors
Algert Global LLC reduced its stake in shares of Globe Life Inc. (NYSE: GL) by 49.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 35,637 shares of the company's stock after selling 34,510 shares during the quarter. Algert
Benchmark GL against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Globe Life Inc. (GL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $169.43 | $13.16B | 12.05 | 3.82% | 19.36% | 20.59% | 0.63% | |
| $53.96 | $5.04B | 22.96 | 0.94% | 6.02% | 10.82% | — | |
| $4.64 | $20.47K | -0.01 | 33.6% | -3.49% | -30.69% | — | |
| $33.84 | $15.08B | -49.76 | 10.03% | 9.65% | 7.09% | — | |
| $41.01 | $7.84B | 7.02 | 1.24% | 12.18% | 21.99% | — | |
| $9.76 | $3.74B | 18.07 | -10.86% | 3.03% | 2.16% | — |
Globe Life Inc. (GL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Globe Life Inc. (GL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 7, 2026·SEC
Jul 22, 2026·SEC
Jun 29, 2026·SEC
Get notified when GL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Globe Life Inc. (GL) stock FAQ — growth, dividends, profitability & financials explained
Globe Life Inc. (GL) grew revenue by 3.8% over the past year. Growth has been modest.
Yes, Globe Life Inc. (GL) is profitable, generating $1.21B in net income for fiscal year 2025 (19.4% net margin).
Yes, Globe Life Inc. (GL) pays a dividend with a yield of 0.63%. This makes it attractive for income-focused investors.
Globe Life Inc. (GL) has a return on equity (ROE) of 20.6%. This is excellent, indicating efficient use of shareholder capital.
Globe Life Inc. (GL) has a combined ratio of 75.6%. A ratio below 100% indicates underwriting profitability.
